Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma
Clinical trial NCT00216424 · TERMINATED
Trial details
- NCT number
- NCT00216424
- Sponsor
- James A. Haley Veterans Administration Hospital
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.